Category Specific RSS

News

Healthia secures Queensland Rugby naming rights till end of 2021

Allied healthcare provider Healthia (ASX: HLA) has strengthened its position as the leading physiotherapy and podiatry provider in Queensland having secured the naming rights for State’s top club rugby competition until the end of 2021.

The Allsports Physiotherapy Hospital Challenge Cup resumed at the start of August following a COVID-19 hiatus and continues Healthia’s long association with Queensland Rugby, increasing the exposure of Healthia’s Allsports Physiotherapy brand.

“Allsports Physiotherapy has a long and proud history of supporting grassroots Rugby in Queensland,” said Healthia Chief Operating Officer, Tony Ganter.

“In 2020 we are happy to continue our support of community-based Rugby, with injury prevention and rehabilitation advice in what has been a challenging year for all Queenslanders and Queensland Rugby players and supporters.”

As part of their contribution to the league, Healthia will supply medical staff and management at each club with various Healthia branded clothing which will feature Allsports Physiotherapy and their podiatry brand My FootDr – the largest podiatry network in Australia.

Beyond Premier Rugby, Brisbane Junior Rugby Union clubs will also be supplied with bibs, vests and injury report cards. Healthia will also assist teams with injury prevention and recovery advice by AllSports physios via social media.

In total, Healthia has 150 physiotherapy and podiatry clinics around Australia but the Company is poised to expand their network further in the coming 12 months with plans to allocate $15 million towards clinic acquisitions.

Despite pandemic-related shutdowns through the first half of 2020, Healthia’s clinics remained open through the period as instructed by the Federal Government, being vital community service that took pressure off the public health system.

Healthia intends to report their FY20 earnings later in August. It will follow their H1 revenue of $44.2 million and EBITDA of $5.7m which represented year-on-year increases of +50.2% and +33.7% respectively.

Investors can register for company updates from Healthia here.


*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago